Currently out of the existing stock ratings of Catherine Novack, 55 are a BUY (96.49%), 2 are a HOLD (3.51%).

Catherine Novack

Work Performance Price Targets & Ratings Chart

Analyst Catherine Novack, currently employed at JONESTRADING, carries an average stock price target met ratio of 33.92% that have a potential upside of 54.92% achieved within 136 days.

Catherine Novack’s has documented 105 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SEPN, Septerna at 13-Aug-2026.

Wall Street Analyst Catherine Novack

Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 9/3/2024. The price target of $12 was fulfilled within 43 days with a profit of $6.45 (116.22%) receiving and performance score of 27.03.

Average potential price target upside

DARE Dare Bioscience KZR Kezar Life Sciences ALDX Aldeyra The FEMY Femasys WVE Wave Life Sciences Ltd CAPR Capricor Therapeutics LRMR Larimar Therapeutics RGLS Regulus Therapeutics CRNX Crinetics Pharmaceuticals DYN Dyne Therapeutics RLYB Rallybio Corp RZLT Rezolute PPBT Purple Biotech CALC CalciMedica PRQR ProQR Therapeutics BV SEPN Septerna KRRO Frequency Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Dec-2020

$12

10 months 19 days ago
(02-Dec-2025)

1/6 (16.67%)

$9.16 (322.54%)

1042

Hold Since 04-Sep-2025

$8

$6.6 (471.43%)

1 years 1 months 17 days ago
(04-Sep-2025)

1/2 (50%)

$5.87 (275.59%)

2316

Buy Since 18-Aug-2025

$11

$9.6 (685.71%)

1 years 2 months 3 days ago
(18-Aug-2025)

1/2 (50%)

$8.89 (421.33%)

203

Buy Since 30-Nov-2022

$13

$11.6 (828.57%)

$5

2 years 2 months 5 days ago
(16-Aug-2024)

2/3 (66.67%)

$9.43 (264.15%)

149

Buy Since 13-Aug-2021

$2

$0.17 (9.29%)

$3

3 years 1 months 21 days ago
(30-Aug-2023)

4/4 (100%)

$-6.52 (-76.53%)

856

Show more analysts

Please expand the browser size to see the chart

Which stock is Catherine Novack most bullish on?

Potential upside of $25.65 has been obtained for SEPN (SEPTERNA)

Which stock is Catherine Novack most reserved on?

Potential downside of -$0 has been obtained for CAPR (CAPRICOR THERAPEUTICS)

What Year was the first public recommendation made by Catherine Novack?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?